Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors.

Arias HR, Feuerbach D, Targowska-Duda KM, Russell M, Jozwiak K.

Biochemistry. 2010 Jul 13;49(27):5734-42. doi: 10.1021/bi100536t. Erratum in: Biochemistry. 2010 Aug 17;49(32):6970.

PMID:
20527991
2.

Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors.

Arias HR, Feuerbach D, Bhumireddy P, Ortells MO.

Int J Biochem Cell Biol. 2010 May;42(5):712-24. doi: 10.1016/j.biocel.2010.01.007.

PMID:
20079457
3.

Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel.

Arias HR, Targowska-Duda KM, Feuerbach D, Sullivan CJ, Maciejewski R, Jozwiak K.

Neurochem Int. 2010 Mar;56(4):642-9. doi: 10.1016/j.neuint.2010.01.011.

PMID:
20117161
4.

Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.

Arias HR, Rosenberg A, Targowska-Duda KM, Feuerbach D, Jozwiak K, Moaddel R, Wainer IW.

Int J Biochem Cell Biol. 2010 Jun;42(6):1007-18. doi: 10.1016/j.biocel.2010.03.002.

5.

Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.

Arias HR, Gu RX, Feuerbach D, Guo BB, Ye Y, Wei DQ.

Biochemistry. 2011 Jun 14;50(23):5263-78. doi: 10.1021/bi102001m.

PMID:
21510634
6.

Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.

López-Valdés HE, García-Colunga J.

Mol Psychiatry. 2001 Sep;6(5):511-9.

7.

Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants.

Gumilar F, Arias HR, Spitzmaul G, Bouzat C.

Neuropharmacology. 2003 Dec;45(7):964-76.

PMID:
14573389
8.

Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human alpha7 nicotinic acetylcholine receptor.

Arias HR, Gu RX, Feuerbach D, Wei DQ.

Biochemistry. 2010 May 18;49(19):4169-80. doi: 10.1021/bi901999v.

PMID:
20377277
9.

Tricyclic antidepressants inhibit homomeric Cys-loop receptors by acting at different conformational states.

Gumilar F, Bouzat C.

Eur J Pharmacol. 2008 Apr 14;584(1):30-9. doi: 10.1016/j.ejphar.2008.01.023.

PMID:
18314100
10.

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

Sánchez C, Meier E.

Psychopharmacology (Berl). 1997 Feb;129(3):197-205.

PMID:
9084057
11.

Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.

Arias HR, López JJ, Feuerbach D, Fierro A, Ortells MO, Pérez EG.

Int J Biochem Cell Biol. 2013 Nov;45(11):2420-30. doi: 10.1016/j.biocel.2013.08.003.

PMID:
23954208
12.
13.

(-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.

Arias HR, Ortells MO, Feuerbach D.

Neurochem Int. 2013 Nov;63(5):423-31. doi: 10.1016/j.neuint.2013.07.009.

PMID:
23917086
14.

The pharmacogenetics of the selective serotonin reuptake inhibitors.

Brøsen K.

Clin Investig. 1993 Dec;71(12):1002-9. Review.

PMID:
8124052
15.

In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.

Hirano K, Maruyama S, Kimura R, Kagawa Y, Yamada S.

Life Sci. 2004 Oct 29;75(24):2933-45.

PMID:
15454344
16.

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Sproule BA, Naranjo CA, Brenmer KE, Hassan PC.

Clin Pharmacokinet. 1997 Dec;33(6):454-71. Review.

PMID:
9435993
17.

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).

Hyttel J.

Int Clin Psychopharmacol. 1994 Mar;9 Suppl 1:19-26. Review.

PMID:
8021435
19.

Inhibitory effect of antidepressants on the NMDA-evoked [(3)H]noradrenaline release from rat hippocampal slices.

Mayer A, Szasz BK, Kiss JP.

Neurochem Int. 2009 Nov;55(6):383-8. doi: 10.1016/j.neuint.2009.04.005.

PMID:
19393275
20.

Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor.

Arias HR, Fedorov NB, Benson LC, Lippiello PM, Gatto GJ, Feuerbach D, Ortells MO.

J Pharmacol Exp Ther. 2013 Jan;344(1):113-23. doi: 10.1124/jpet.112.197905.

Supplemental Content

Support Center